Besides somatic mutations, BRCA1 promoter hypermethylation and decreased BRCA1 expression, by epigenetic silencing or gene depletion, can also render a dysfunctional BRCA1 pathway in non-hereditary cancers [16,81]. This evidence concerns the gene BRCA1 and cancer.